Skip to main content
Back to OrbiMed

OrbiMed's Artificial Intelligence (AI) Portfolio

Browse 5 Artificial Intelligence (AI) companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Artificial Intelligence (AI) Companies
5
Total Funding in Artificial Intelligence (AI)
$332.0M

Artificial Intelligence (AI) Portfolio Companies (5)

Export
Artificial Intelligence (AI)BiotechnologyLife ScienceMedicalTherapeutics

Evozyne is a generative AI company that focuses on therapeutic discovery and drug development.

Chicago, United States
September 2023
$81.0M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Health CareHome Health CareMachine LearningMedical DevicemHealthSoftwareTelehealth

TytoCare is a telehealth platform for AI-powered and on-demand remote medical examinations.

New York, United States
August 2023
$49.0M
Series E

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyLife Science

CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins.

London, United Kingdom
April 2023
$20.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaMedical

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

San Francisco, United States
January 2026
$82.0M
Series A

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Machine LearningSoftwareTherapeutics

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

San Diego, United States
November 2025
$100.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio
OrbiMed Artificial Intelligence (AI) Portfolio - 5 Companies | VCBacked